Literature DB >> 2459241

Inhibition by IL-1 of endothelial cell activation induced by tumor necrosis factor or lymphotoxin.

D E Cavender1, D Edelbaum.   

Abstract

Previous studies in this and other laboratories have demonstrated that IL-1, lymphotoxin (LT), and TNF rapidly stimulate a number of proinflammatory properties in cultured endothelial cells (EC) including cell-surface procoagulant activity and increased adhesivity for lymphocytes, monocytes, and polymorphonuclear leukocytes. In addition, we have demonstrated that LT and TNF, but not IL-1, stimulate increases in EC RNA synthesis, protein synthesis, and cellular volumes, changes which may correspond to the hypertrophy of EC seen at sites of inflammation in vivo. It is reported here that both human rIL-1 alpha and rIL-1 beta totally inhibit the increases in EC RNA synthesis, protein synthesis, and cell volumes induced by either TNF or LT. As little as 0.1 ng/ml of either IL-1 was sufficient to totally block the activation of EC induced by 100-fold higher concentrations (10 ng/ml) of either LT or TNF. The relevance of these findings to the regulation of inflammatory responses is discussed.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 2459241

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  3 in total

1.  Interleukin-1 alpha inhibits the effects of gamma-interferon and tumor necrosis factor alpha on the expression of the major histocompatibility antigens by the rat endothelium.

Authors:  D Leszczynski
Journal:  Am J Pathol       Date:  1990-01       Impact factor: 4.307

2.  Development of multiple necrotizing enteritis induced by a tumor necrosis factor-like cytokine from lipopolysaccharide-stimulated peritoneal macrophages in rats.

Authors:  K Torimoto; N Sato; M Okubo; A Yagihashi; Y Wada; I Hara; H Hayasaka; K Kikuchi
Journal:  Am J Pathol       Date:  1990-11       Impact factor: 4.307

3.  Immunohistological identification of interleukin-1 activated chondrocytes.

Authors:  J T Dingle; M E Davies; B Y Mativi; H F Middleton
Journal:  Ann Rheum Dis       Date:  1990-11       Impact factor: 19.103

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.